Tegafur,gimeracil And Oteracil Potassium Capsules60

Product Name:Tegafur,gimeracil And Oteracil Potassium Capsules
Product Description:
Tegafur,gimeracil and oteracil potassium capsulesIntroductionHard capsule,a white or similar white particles or powder inside.??IndicationsGastric cancer, colorectal cancer, head and neck cancers, non-small-cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer, and biliary tract cancer..?IngredientsTegafur:20mg, Gimeracil:5.8mg, Oteracil potassium:19.6mg;.?Use & DosageUsually, the standard doses below are defined as the initial dose (single dose) for adults according to body surface area. TS-1 is administered twice daily, after breakfast and after the evening meal, for 28 consecutive days, followed by a 14-day rest. This is regarded as one course of the regimen.??Body surface area (m2) ? ? Initial dose (tegafur equivalent)?? ? ? ? ? ? ? < 1.25 ? ? ? ? ? ? ? ? ? ? ? 40 mg each time? ? 1.25 - < 1.5 ? ? ? ? ? ? ? ? ? ? ? ?50 mg each time?≥ 1.5 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?60 mg each timeThe initial dose can be decreased or increased according to the patient's condition. The doses are staged thus: 40 mg, 50 mg, 60 mg, and 75 mg. If no drug-induced abnormalities in laboratory findings (hematological tests, liver and renal function tests) and no gastrointestinal symptoms occur, i.e., the drug is not problematic in terms of safety, and it is decided to increase the dose, the initial dose can be increased one stage, with an upper limit of 75 mg. It can also be decreased by one stage, and the lower limit is 40 mg.?Clinical PharmacologyMechanism Of ActionTegafur is the actual chemotherapeutic agent. It is a prodrug of the active substance fluorouracil (5-FU).Gimeracil inhibits the degradation of fluorouracil by reversibly blocking a dehydrogenase enzyme. This results in higher 5-FU levels and a prolonged half-life of the substance.Oteracil mainly stays in the gut because of its low permeability, where it reduces the production of 5-FU by blocking the enzyme orotate phosphoribosyltransferase. Lower 5-FU levels in the gut result in a lower gastrointestinal toxicityRelated Keywords:China Tegafur,Gimeracil and Oteracil Potassium Capsules manufacturer,China Tegafur Capsules suppliers,Tegafur,Gimeracil and Oteracil Potassium Capsules from China professional pharmaceutical factory,Oncology Drugs , Oncology Nursing Drug , Oncology And Supplementary Drug , Oncology Drugs Manufacturers , Oncology Drugs Suppliers , China Oncology Drugs , Tegafur,Gimeracil and Oteracil Potassium Capsules
Price:10.00
Product Website:[Misafirler Kayıt Olmadan Link Göremezler Lütfen Kayıt İçin Tıklayın ! ]
Company Description
Sundent Pharm Group
Address:ShanghaiShanghaiShanghaiSongjiangNo.1333 Xinlong Road, Shanghai.China.
Descption:Sundent Pharm Group (together with its subsidiaries, the Group�) is one of the largest comprehensive manufacturing, marketing, promotion and channel management service provider dedicated to pharmaceutical products.? Since establishment in 2004, the Group has determined to apply global vision to local management, and has introduced a series of pharmaceutical products embedded with technologies that represent international advanced level to China, South America, Eastern European and south Asia countries.? As of Dec 2015, the company had portfolio of pharmaceutical products, covering pain management, cardiovascular, respiratory, gastroenterology, immunology and other therapeutic areas.? At the same time, the Group endeavors to uplift the market value of these brands.

With a global horizon and well-deserved creditability in international market development, the Group has established long-term and stable cooperation with a number of renowned Chinese pharmaceutical manufacturer leaders, independent product quality analysis and develop centers, Chinese SFDA etc., The network lays the foundation of the sustainable development of the company through the comprehensive and effective products introduction and cooperation.

Looking into the future, the Group is committed to build itself into a cutting-edge pharmaceutical manufacturing and marketing group company that grasps the sales channel and product pricing advantage in mainland China. We believe that, with rapid development of China's pharmaceutical industry, through an open-minded attitude, perspective new product introduction capability, accurate product marketing strategy, comprehensive marketing network and effective management system, Sundent Pharmaceutical Group is able to achieve our development target.
Registered Capital:50
EmployeeNum:50
Sundent Pharm Group
Contact:Tracy zhang
Telphone:86-21-67897115-0
Fax:86-21-67897115-802
Email:Sundent@aliyun.com
Company Website:[Misafirler Kayıt Olmadan Link Göremezler Lütfen Kayıt İçin Tıklayın ! ]